Dermatosis perforante adquirida
Keywords:
Dermatosis perforante, diabetes mellitus, alopurinolAbstract
Las colagenosis perforantes adquiridas son trastornos cutáneos infrecuentes. Se caracterizan por pápulas y nódulos hiperqueratóticos, y su histología revela eliminación transepidérmica de varias sustancias como queratina, colágeno y fibras elásticas. La enfermedad se origina en la adultez, usualmente
en asociación con diabetes mellitus o falla renal crónica. El alopurinol ha demostrado ser un recurso terapéutico valioso para su manejo.
Author Biographies
Fabián Andrés Hernández Velasco, Universidad de Caldas
RIII Dermatología, Universidad de Caldas, Manizales
Lucia Van Den Enden Medina, Universidad de Caldas
Docente Dermatología, Universidad de Caldas, Manizales
References
1. Ohe S, Danno K, Sasaki H, Hiroyuki TI, Horio T. Treatment of acquired perforating dermatosis with narrowband ultraviolet B. J Am Acad Dermatol 2004; 50: 892- 4.
https://doi.org/10.1016/j.jaad.2004.02.009
2. Saray Y, Se9kin D, Bilezik<;;i B. Acquired perforating dermatosis: clinicopathological features in twenty-two cases. J Eur Acad Dermatol Venereol 2006; 20: 1-1 O.
https://doi.org/10.1111/j.1468-3083.2006.01571.x
3. Abdelbaqi-Salhab M, Shalhub S, Morgan M. A current review of the cutaneous manifestations of renal disease. J Cutan Pathol 2003; 30: 527- 38.
https://doi.org/10.1034/j.1600-0560.2003.00109.x
4. Kawakami T, Saito R. Acquired reactive perforating collagenosis associated with diabetes mellitus: eight cases that meet Faver's criteria. Br J Dermatol 1999, 140: 521-4.
https://doi.org/10.1046/j.1365-2133.1999.02722.x
5. Hoque SR, Ameen M, Holden CA. Acquired reactive perforating collagenosis: tour patients with a giant variant treated with allopurinol. Br J Dermatol 2006, 154:759-62.
https://doi.org/10.1111/j.1365-2133.2005.07111.x
https://doi.org/10.1016/j.jaad.2004.02.009
2. Saray Y, Se9kin D, Bilezik<;;i B. Acquired perforating dermatosis: clinicopathological features in twenty-two cases. J Eur Acad Dermatol Venereol 2006; 20: 1-1 O.
https://doi.org/10.1111/j.1468-3083.2006.01571.x
3. Abdelbaqi-Salhab M, Shalhub S, Morgan M. A current review of the cutaneous manifestations of renal disease. J Cutan Pathol 2003; 30: 527- 38.
https://doi.org/10.1034/j.1600-0560.2003.00109.x
4. Kawakami T, Saito R. Acquired reactive perforating collagenosis associated with diabetes mellitus: eight cases that meet Faver's criteria. Br J Dermatol 1999, 140: 521-4.
https://doi.org/10.1046/j.1365-2133.1999.02722.x
5. Hoque SR, Ameen M, Holden CA. Acquired reactive perforating collagenosis: tour patients with a giant variant treated with allopurinol. Br J Dermatol 2006, 154:759-62.
https://doi.org/10.1111/j.1365-2133.2005.07111.x
How to Cite
1.
Hernández Velasco FA, Van Den Enden Medina L. Dermatosis perforante adquirida. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 2006 Dec. 1 [cited 2024 Jul. 3];14(4):389-91. Available from: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/500
Downloads
Download data is not yet available.
Downloads
Published
2006-12-01
How to Cite
1.
Hernández Velasco FA, Van Den Enden Medina L. Dermatosis perforante adquirida. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 2006 Dec. 1 [cited 2024 Jul. 3];14(4):389-91. Available from: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/500
Issue
Section
Minicases
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
